Instil Bio, Inc. (TIL)
7.15
+0.01
(+0.14%)
USD |
NASDAQ |
Sep 30, 16:00
7.15
0.00 (0.00%)
After-Hours: 17:47
Instil Bio Market Cap : 48.49M for Sept. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 29, 2026 | 48.42M |
| September 28, 2026 | 47.75M |
| September 25, 2026 | 48.63M |
| September 24, 2026 | 48.29M |
| September 23, 2026 | 49.07M |
| September 22, 2026 | 48.36M |
| September 21, 2026 | 47.95M |
| September 18, 2026 | 48.08M |
| September 17, 2026 | 48.90M |
| September 16, 2026 | 48.69M |
| September 15, 2026 | 48.90M |
| September 14, 2026 | 50.53M |
| September 11, 2026 | 50.05M |
| September 10, 2026 | 49.92M |
| September 09, 2026 | 51.41M |
| September 08, 2026 | 53.04M |
| September 04, 2026 | 51.41M |
| September 03, 2026 | 51.95M |
| September 02, 2026 | 52.12M |
| September 01, 2026 | 52.15M |
| August 31, 2026 | 51.61M |
| August 28, 2026 | 51.41M |
| August 27, 2026 | 53.31M |
| August 26, 2026 | 53.10M |
| August 25, 2026 | 51.54M |
| Date | Value |
|---|---|
| August 24, 2026 | 52.97M |
| August 21, 2026 | 51.41M |
| August 20, 2026 | 50.39M |
| August 19, 2026 | 50.12M |
| August 18, 2026 | 49.58M |
| August 17, 2026 | 49.92M |
| August 14, 2026 | 50.05M |
| August 13, 2026 | 49.31M |
| August 12, 2026 | 50.73M |
| August 11, 2026 | 50.80M |
| August 10, 2026 | 50.25M |
| August 07, 2026 | 50.25M |
| August 06, 2026 | 49.37M |
| August 05, 2026 | 49.24M |
| August 04, 2026 | 49.17M |
| August 03, 2026 | 48.97M |
| July 31, 2026 | 48.29M |
| July 30, 2026 | 48.42M |
| July 29, 2026 | 48.97M |
| July 28, 2026 | 49.44M |
| July 27, 2026 | 48.49M |
| July 24, 2026 | 48.36M |
| July 23, 2026 | 48.83M |
| July 22, 2026 | 49.17M |
| July 21, 2026 | 49.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.466B |
| Alnylam Pharmaceuticals, Inc. | 33.01B |
| Anika Therapeutics, Inc. | 263.24M |
| Savara, Inc. | 1.058B |
| Vericel Corp. | 2.053B |
Market Cap Related Metrics
| Price to Book Value | 0.4516 |
| Price | 7.15 |
| Earnings Yield | -62.55% |